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Abstract 44 
Background 45 
Antipsychotic prescribing is prevalent in nursing homes for the management of behavioral and 46 
psychological symptoms of dementia (BPSD), despite the known risks and limited effectiveness. 47 
Many studies have attempted to understand this continuing phenomenon, utilizing qualitative 48 
research methods, and have generated varied and sometimes conflicting findings. To date, the 49 
totality of this qualitative evidence has not been systematically collated and synthesized.  50 
Aims 51 
To synthesize the findings from individual qualitative studies on decision-making and prescribing 52 
behaviors for antipsychotics in nursing home residents with dementia, with a view to informing 53 
intervention development and quality improvement in this field. 54 
Methods 55 
A systematic review and synthesis of qualitative evidence was conducted (PROSPERO protocol 56 
registration CRD42015029141). Six electronic databases were searched systematically from 57 
inception through July 2016 and supplemented by citation, reference and gray literature searching. 58 
Studies were included if they utilized qualitative methods for both data collection and analysis, and 59 
explored antipsychotic prescribing in nursing homes for the purpose of managing BPSD. The Critical 60 
Appraisal Skills Programme (CASP) assessment tool was utilized for quality appraisal. A meta-61 
ethnography was conducted to synthesize included studies. The Confidence in the Evidence from 62 
Reviews of Qualitative research (CERQual) approach was used to assess the confidence in individual 63 
review findings. All stages were conducted by at least two independent reviewers. 64 
Results 65 
Of 1,534 unique records identified, 18 met the inclusion criteria.  Five key concepts emerged as 66 
influencing decision-making: Organizational Capacity; Individual Professional Capability; 67 
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Communication and Collaboration; Attitudes; Regulations and Guidelines. A ‘line of argument’ was 68 
synthesized and a conceptual model constructed, comparing this decision-making process to a 69 
dysfunctional negative feedback loop. Our synthesis indicates that when all stakeholders come 70 
together to communicate and collaborate as equal and empowered partners, this can result in a 71 
successful reduction in inappropriate antipsychotic prescribing. 72 
Conclusion 73 
Antipsychotic prescribing in nursing home residents with dementia occurs in a complex environment 74 
involving the interplay of various stakeholders, the nursing home organization and external 75 
influences. In order to improve the quality of antipsychotic prescribing in this cohort, a more holistic 76 
approach to BPSD management is required. While we have found the issue of antipsychotic 77 
prescribing has been extensively explored using qualitative methods, there remains a need for 78 
research focusing on how best to change the prescribing behaviors identified.  79 
Keywords 80 
Antipsychotic; Prescribing Behavior; Dementia; Nursing Home; Qualitative Research; Systematic 81 
Review 82 
Introduction 83 
Antipsychotics are commonly prescribed to manage the behavioral and psychological symptoms of 84 
dementia (BPSD).1 These medications have a role to play in BPSD when there is a danger of harm to 85 
self or others, when there is a psychosis, or when non-pharmacological approaches have not been 86 
effective.2 However, these agents are often prescribed inappropriately, despite evidence of an 87 
increased risk of stroke and mortality, and a lack of effectiveness in these patients.1,3,4 People with 88 
dementia are prescribed significantly more of these agents than the general older population,5,6 and 89 
it is in the nursing home setting where the majority of this prescribing occurs. 7 90 
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A 2014 systematic review found that many interventions are effective in the short-term at reducing 91 
the inappropriate prescribing of antipsychotics in nursing homes to people with dementia.8 The 92 
authors highlighted the need for a greater understanding of the contextual drivers of inappropriate 93 
prescribing in order to improve the long-term sustainability of the reviewed interventions. 94 
Qualitative research allows for a rich understanding of complex social environments such as nursing 95 
homes and can be used to develop and improve interventions in this context.9 A number of original 96 
qualitative studies have been conducted on antipsychotic prescribing in people with dementia but to 97 
date these have not been the subject of a systematic review. 98 
The most commonly utilized method for synthesizing qualitative evidence is  meta-ethnography.10 99 
This seven-step method of qualitative evidence synthesis employs an inductive approach moving 100 
from specific observations to broader generalizations. It is a systematic interpretive approach that is 101 
particularly useful for generating new theories or concepts, which can influence policy and 102 
practice.11 For example, recently published clinical guidelines on multimorbidity12 have been 103 
informed by a high-quality meta-ethnography in this similarly complex field.13  104 
The aim of our study was to synthesize the findings from individual qualitative studies in order to 105 
develop novel interpretations of the influences on decision-making regarding the prescribing of 106 
antipsychotics in nursing home residents with dementia, with a view to informing intervention 107 
development and quality improvement in this field. 108 
Methods 109 
We conducted a systematic search of primary qualitative studies exploring antipsychotic prescribing 110 
in non-acute, long-term care institutions. We used a ‘meta-ethnographic synthesis’,10 as adapted by 111 
Atkins et al,14 to guide our methods. The review protocol was registered with the PROSPERO 112 
international prospective register of systematic reviews (registration number: CRD42015029141).  113 
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Six electronic databases were searched from inception to July 2016; Medline, PubMed, EMBASE, 114 
CINAHL, PsycINFO and Academic Search Complete. Database-specific search strategies were 115 
developed with assistance from a medical librarian. Search terms included a combination of Medical 116 
Subject Heading terms, keywords and a comprehensive list of synonyms of the following: ‘dementia’ 117 
AND ‘prescription’ AND ‘antipsychotic agents’ with the aim of being as sensitive as possible. The 118 
search was not limited by dates of publication or country of origin. To supplement the database 119 
search, we conducted hand-searches of key journals and conference proceedings; citation searches 120 
of highly cited key studies; reviews of reference lists of key studies; and contacted authors of 121 
relevant conference abstracts and studies. The gray literature search was further supplemented by 122 
checking the first 100 hits from Google Scholar and by consulting the websites and key personnel 123 
from various international Alzheimer’s Societies (supplementary material table S1). 124 
We included any English-language, peer-reviewed primary study, published in full, using recognized 125 
qualitative research methods of both data collection and analysis. Mixed-methods studies were only 126 
included if they utilized qualitative methods as a component of the study. Only the qualitative 127 
components of these studies were extracted for analysis. We only included questionnaire studies if 128 
the written comments had been analyzed using qualitative methods. 129 
For the first stage of study selection, one reviewer (KW) conducted preliminary screening of titles to 130 
exclude records that were clearly not relevant (e.g. pre-clinical studies). For the second stage, two 131 
reviewers (KW and RD) independently screened titles and abstracts, against inclusion criteria, to 132 
identify potentially relevant studies. In the third stage, two reviewers (KW and RD) independently 133 
reviewed full texts of studies. Consensus on inclusion in stages two and three was reached by 134 
discussion between both reviewers, with arbitration by a senior reviewer (ST) if required. The Critical 135 
Appraisal Skills Programme (CASP) assessment tool for qualitative research was used to assess the 136 
quality of included studies,15 by two reviewers (KW and JB) independently, and consensus was 137 
reached by discussion. Studies were not excluded based on the assessed level of quality. 138 
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Methodological limitations of included studies were accounted for in the ‘Confidence in Evidence 139 
from Reviews of Qualitative research’ (CERQual) assessments (discussed below).16 140 
Four reviewers (KW, RD, EC and CS) read and re-read the included studies, with a focus on the 141 
content and context. As a group, we identified what we believed to be the conceptually-richest 142 
‘index paper’,17 and used this as the starting point. Three reviewers (KW, RD and EC) read all 18 143 
included studies starting with the ‘index paper’ and then chronologically. One reviewer (KW) open 144 
coded the study findings of all included studies (results and discussion sections), focusing specifically 145 
on first-order interpretations (views of the participants) and second-order interpretations (views of 146 
the authors). To ensure credibility and dependability of coding, another reviewer (CS) coded the 147 
‘index paper’ and two other randomly selected studies,18,19 and differences in interpretation were 148 
discussed and consensus reached.20 The four reviewers convened several times to discuss 149 
independently derived concepts and patterns from the studies. Reflexivity was preserved as one 150 
reviewer (KW) conducted memo writing.20  As a multidisciplinary group, we were cognisant of our 151 
professional biases, therefore we ensured that there was a balance between clinical (KW and CS) 152 
and non-clinical (EC and RD) reviewers at this stage.  153 
Collectively, we developed five key concepts to reflect the main findings of all included studies. We 154 
developed a matrix of these concepts and assessed how each individual study related to each 155 
concept. Two reviewers (KW and SB) independently extracted data regarding contextual information 156 
from each included study. Discrepancies were resolved through discussion between both reviewers. 157 
QSR International’s NVivo version 11 was used to assist with data analysis and synthesis.21 158 
In line with the constant comparative method of qualitative analysis,22 the first- and second-order 159 
interpretations were compared and contrasted across primary studies to identify similarities and 160 
disagreements. The importance of context to each interpretation was carefully observed. In this 161 
way, reciprocal and refutational translations were conducted.11 All eight reviewers were involved in 162 
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this and the following stages to ensure no important meanings were lost upon translating one study 163 
into the next. 164 
We collaboratively developed third-order interpretations by synthesizing first- and second-order 165 
interpretations, from each study. The synthesis required refining the key concepts and building on 166 
the analysis iteratively. This process was repeated until we were satisfied that the third order 167 
interpretations added to, but were still representative of, the findings of the total dataset. These 168 
interpretations act as testable, novel hypotheses, which are still grounded in the data.14 We then 169 
linked these using a ‘line of argument’ in order to develop an overarching conceptual model 170 
explaining the phenomenon.13 Noblit and Hare describe this ‘line of argument’ synthesis as a means 171 
of uncovering novel understandings that were hidden in the individual studies (discovering a ‘whole’ 172 
among a set of parts).10  173 
We reported our results in line with the ‘Enhancing Transparency in Reporting the Synthesis of 174 
Qualitative Research’ (ENTREQ) statement23 (supplementary material table S2),  and expressed our 175 
search strategy results as a ‘Preferred Reporting Items for Systematic Reviews and Meta-Analyses’ 176 
(PRISMA) flow diagram24 (Fig. 1). To present the findings of the review in a manner useful for policy-177 
makers, we used CERQual.16 This tool allows assessment of the confidence in synthesized qualitative 178 
findings. We assessed the extent to which the review findings (i.e. third-order interpretations) were 179 
reasonable representations of the phenomenon of interest, by independent application of CERQual, 180 
by two reviewers (KW and RD), with discussion until consensus was reached. 181 
Results 182 
Search Results 183 
A total of 1,534 unique records were found after duplicate removal (Fig. 1).24 After the exclusion of 184 
records based on title screening (n=631) and subsequent title and abstract screening (n=800), the 185 
remaining 103 full texts were assessed for eligibility. We excluded 85 records at this stage (Fig. 1, 186 
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and supplementary material table S3). In our final review, we included 18 studies describing 17 study 187 
cohorts.  188 
Characteristics of Included Studies 189 
Table 1 outlines the characteristics of the 18 included studies. The studies were conducted in six 190 
different countries: UK (n=7),19,25-30 US (n=5),18,31-34 Australia (n=3),35-37 Canada (n=1),38 The 191 
Netherlands (n=1)17 and South Africa (n=1).39 Eleven of the studies employed a purely qualitative 192 
methodology,17-19,25-27,30,35-37,39 while seven utilized mixed-methods.28,29,31-34,38 A total of 1,609 unique 193 
participants were involved: nurses (n=479), other nursing home staff (n=657), family carers (n=239), 194 
physicians (n=144), pharmacists (n=49) and old age advocates (n=6). One study did not provide a 195 
disciplinary breakdown for its 35 participants.18 No study included the voice of the person with 196 
dementia. Of the 114 included nursing homes that had their ‘for-profit’ status described, 68 were 197 
for-profit, 40 were not-for-profit and 6 were described as “other.”  198 
Quality Appraisal  199 
The overall quality of included studies was assessed to be moderate to high for 17 of the 18 studies 200 
(Table 2). A common weakness, found in twelve studies, was inadequate researcher 201 
reflexivity.17,18,25,27-33,35,39 The relationship between the researcher and participants had not been 202 
effectively addressed in these studies. The overall quality of one study was assessed to be low due to 203 
concerns across several CASP domains.28 Despite these weaknesses, we believed that on the whole, 204 
these studies were sufficiently robust to contribute to our meta-ethnography and to the 205 
development of our conceptual model. 206 
Translation  207 
We identified five key concepts (in bold and numbered) encompassing eight sub-themes (in bold) 208 
that reflected the main influences on this decision-making process. These are reported below 209 
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supported by first-order (italicized quotations) and second-order (non-italicized quotations) 210 
interpretations (supplementary material Table S4). 211 
The complexity of the decision-making process was evident throughout. Overall, “the aim of 212 
improving care” for residents was a priority,25 but there was tension as to how this was best 213 
achieved. The options for managing BPSD were generally perceived to be binary – antipsychotic 214 
prescribing or non-pharmacological interventions - with the former option considered to be the 215 
“quick-fix.”19,26,38  216 
1. Organizational Capacity 217 
Resources and access to services: Understaffing and insufficient time to engage with residents, to 218 
conduct thorough assessments of underlying causes, and perform non-pharmacological 219 
interventions was mentioned throughout the reviewed studies:17-19,26,27,29,30,32,33,35-39 "The greatest 220 
impact on good outcomes for behaviour management is time limits. Nurses are always under 221 
pressure to hurry."35 In some studies there was a suggestion that medication was used to 222 
compensate for poor staffing levels:19,37 “sometimes [it’s] easier to give a tablet.”19 This understaffing 223 
issue was further compounded by a lack of access to specialist services such as psychiatrists, 224 
therapists and pharmacists.25,26,29,32,33 225 
In some studies, nursing home managers working in the public sector stated that there was very 226 
little they could do to solve staff shortages due to the lack of funding.29,32,37 Financial issues were a 227 
parallel concern in private sector nursing homes, and were associated with the use of antipsychotics 228 
as a means to deal with constrained expenditure on staff:17,26,37 “The desire to make money means 229 
that [managers] have to make choices about staffing levels and staffing quality that is good for the 230 
money making side but not necessarily good for the patient side… That’s where controlling and 231 
managing the patient might come in.”37 232 
Coping with the severity of behaviors: Many studies reported a struggle to manage residents with 233 
severe behavioral problems.17,26,30,31,38,39 Nurses reported  that they were constantly “putting out 234 
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fires,”38 causing them to feel  “overwhelmed.”37 Prescribers reported that “they had little option but 235 
to prescribe” to help relieve these situations.26  Consequently, staff felt they were “letting the 236 
residents down,”30 thus contributing to poor staff morale.30,31,33,37,39 237 
Nursing home staff reported conflicting priorities. Dealing with escalating behavioral issues could be 238 
perceived as a barrier to completing other nursing tasks:18,30,35,38 “Medications were viewed as a 239 
resource that allowed nurses… to reduce the agitation and complete daily care tasks successfully.”38  240 
2. Individual Professional Capability 241 
Skills: Possessing the necessary skills was considered critical for effective BPSD management.17-19,26-242 
35,37-39 Staff and family members realized the importance of good interpersonal skills when dealing 243 
with residents,27,31,39 because approaching residents “in the wrong way” could trigger behavioral 244 
symptoms27 , while good interpersonal skills could have a positive effect.27 245 
There was a belief that some staff, particularly newly qualified healthcare assistants, were not 246 
adequately trained to deal with behavioral symptoms.18,26,30,37,39 Prescribers commented that these 247 
deficiencies were contributing towards the pressure to prescribe antipsychotics26 “to ensure that 248 
there is no colorful behavior.”37 249 
In some studies, staff appeared unable to effectively apply a range of individualized non-250 
pharmacological interventions to the residents.18,35,38 Participants noted that familiarity with the 251 
resident, training, sharing of experiences and practice improved their confidence in applying non-252 
pharmacological approaches.18,30,32,34,35,37-39 253 
Knowledge: In several studies, both prescribers and staff were perceived to lack adequate 254 
knowledge on the risks and benefits of antipsychotics,17,19,28,32,34,35 and to lack awareness regarding 255 
the nature and range of alternative approaches.18,26,29,32,34,35,38 In one study, prescribers believed 256 
nurses and family members expressed “unfounded high expectations” of the effectiveness of 257 
antipsychotics,17 while in other studies, staff felt that it was the prescribers who did not have enough 258 
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knowledge.19,29,32 The authors of one study concluded “that poor staff knowledge of appropriate use 259 
of antipsychotics may underlie the high rate of administration, despite the reported limitations to its 260 
use.”35  261 
There was a strong desire by participants for more hands-on, interdisciplinary training and 262 
education,18,29,30,32-35,37-39 that can “help staff relinquish the need for control in favor of 263 
understanding.”18 264 
Knowing the resident and understanding their individual behaviors was critical to performing 265 
person-centered care.17-19,25,27,30,31,35-39 However this took a lot of time, staff consistency and close 266 
involvement with the family, which was not always possible.17-19,27,30,31,36,38,39  267 
3. Communication and Collaboration 268 
Communication within healthcare teams and with the family: Effective communication was viewed 269 
as an essential component to successful BPSD management.17-19,25-33,36-38 Good communication 270 
between all those involved in the care of residents, with close involvement of the family, promoted a 271 
sense of trust and mutual respect.17,25-27,30-33,36-38 Listening to concerns and valuing everybody’s 272 
opinion was critical,17,19,25,28-30,36,37 and participants felt that “by jointly looking at the problems and by 273 
learning from each other… we gained more clarity, much more peace, and also had a significant 274 
decrease in prescribed medication.”17  275 
Working together, with a shared goal, was perceived to be essential.17,19,25,27,29,30,32,33,36-38 276 
Interdisciplinary medication reviews were good examples of different stakeholders working together 277 
to reduce inappropriate antipsychotic use.17,25,32,36 278 
In contrast, poor communication and collaboration led to sub-standard dementia care.18,19,25,28-32,35-37 279 
Staff saw themselves as a “cog in a wheel”: if they all worked together everything ran smoothly, but 280 
if one person was not pulling their weight, the whole system fell apart.30 One study discussed issues 281 
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regarding primary care physicians not attending medication review meetings and the subsequent 282 
barrier this presented to reducing inappropriate antipsychotic prescribing.36 283 
Clarity of Roles and Responsibilities: There was a sense of uncertainty regarding roles and 284 
responsibilities in relation to antipsychotic prescribing, particularly between different care 285 
settings.25,26,28-30,32,35,37 Primary care physicians felt that the responsibility for antipsychotic 286 
prescriptions belonged to the hospital physician who initiated them, “as the psychiatrist started it 287 
they will not stop prescribing it.”29 In some studies, this caused “confusion,”29 which promoted the 288 
belief that it was the  job of nursing home staff “to clean up the situation.”33  289 
A perception of being a victim of professional hierarchy was raised in several studies.19,25,29,36,37,39 In 290 
these studies, staff felt unable to question the prescriber in relation to the appropriateness of a 291 
prescription,19,36,37 due to the existence of “professional norms that were very traditional and 292 
hierarchical in nature.”37 However in other studies, it was the prescriber who did not feel 293 
empowered to say no to a request from nurses,17,25,26,29,37 because “they [nurses] want it and it’s very 294 
difficult to refuse.”25  295 
4. Attitudes towards people with dementia and the management of BPSD 296 
Personal Attitudes: Attitudes towards antipsychotics were on a spectrum,17-19,25,27-31,33,35,38-40 ranging 297 
from being viewed as “really beneficial”19 to “chemical cosh.”28 Participants in some studies were 298 
concerned by their usage and believed the side-effect profile to be unacceptable.17,18,26-28,30,33,35-39 299 
Other participants had a more “pro medicine” attitude,38 and it appeared that they might have used 300 
antipsychotics for convenience.18,19,30,38  301 
Participants in several studies believed that antipsychotics were required for the greater good.18,37,38 302 
Primary care physicians in one study considered the potentially serious side effects “a worthwhile 303 
trade-off” if they improved residents’ quality of life,29 and in another study perceived them as a 304 
“necessary evil,” to help staff deal with their high workload.37  305 
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Participants generally held positive views towards people with dementia27,30,37-39 and “expressed 306 
great empathy with residents.”39 However participants in some studies voiced dismissive attitudes 307 
towards people with dementia,19,30,31,37,39 and expressed a desire to manage the resident rather than 308 
assess the underlying cause.17-19,26,28,30,37 In one study, a staff member stated that they found 309 
residents’ behaviors “annoying.”19 310 
Fear of behavior recurrence was expressed in several studies,17,25,28,30,31,39 hence “there can even be 311 
resistance from nurses and family to withdraw [antipsychotics], especially when considerable effort 312 
was put into stabilizing the [behaviors].”17 313 
Organizational and Societal Attitudes: The pressure to prescribe from nursing homes was a key 314 
finding in a number of studies. 17,19,25,26,29,36-38 One primary care physician admitted that this pressure 315 
to prescribe forced them to withdraw their medical services to a particular nursing home as they felt 316 
it was at odds with evidence-based practice.37  317 
Managers were seen to play a key role in communicating messages about best practice.27,30,36,37,39 318 
Managers that emphasized the value of non-pharmacological approaches created a culture where 319 
alternative approaches were exhausted before antipsychotics were used. One pharmacist observed 320 
that: “If the attitude’s right at the top, then it filters through. If you have management that don’t 321 
really do the right thing or don’t really care, then that filters through as well.”37 In most studies 322 
management culture was highlighted as a driver of the quality of healthcare provided.18,19,27,30-32,34-39  323 
5. Regulations and Guidelines: Regulations and guidelines produced mixed 324 
reactions.17,18,26,29,32,33,36 Regulations were perceived as the “driving force” for improving standards in 325 
nursing homes,18 but prescribers expressed “ambivalence” towards the influence of guidelines.17 326 
Regulations were only mentioned in studies conducted in the US18,32-34 and Australia.36 According to 327 
one US study author: “regulatory oversight has altered the landscape.”18 In Australia, although the 328 
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conduct of pharmacist-led medication reviews were mandatory for residential settings, there was 329 
great variability between nursing homes in how the resultant recommendations were utilized.36  330 
Guidelines were perceived to be less influential with regards to changing antipsychotic 331 
prescribing.17,26,29 In one study, prescribers felt that guidelines were unhelpful as they often 332 
contradicted their own clinical experience and caused “more problems.”26 Prescribers from another 333 
study argued that some guidelines could be interpreted to allow for greater levels of prescribing.17 334 
“What was more influential was past experience of a drug, although guidelines… were taken into 335 
account.”26  336 
The Impact of Context on Findings 337 
The professional background of the research team tended to influence the focus of inquiry of 338 
included studies. In general, researchers from a nursing or social science background tended to focus 339 
on the person with dementia, in an attempt to understand these behavioral issues:18,27,28,30,31,38,39 340 
“they’re frustrated because they can’t explain how they’re feeling.”27 Whereas researchers from a 341 
medical or pharmacy background tended to focus on more structural (e.g. resources) or 342 
organizational (e.g. interprofessional relationships) issues:17,25,26,29,32-34,36,37 “homes are dealing with a 343 
greater level of illness and disturbance than they were designed for.”26 However there were some 344 
contradictions and not every study followed this pattern.19,35 Furthermore, the majority of included 345 
studies explored both perspectives to varying degrees.17-19,27-30,33,35-39 346 
Time has also impacted on the findings. The earliest of these studies, published in 2003, discussed 347 
antipsychotics as an option for BPSD management, without necessarily attributing  positive or 348 
negative connotations to this practice.31 However studies published since (2007-2016), have 349 
generally advocated a more cautious approach.17-19,25-28,30,32-39 This is possibly due to the publication 350 
of a meta-analysis in 2005 providing evidence of the risks associated with antipsychotic prescribing 351 
in people with dementia.3 352 
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Synthesis 353 
Synthesizing these first- and second-order interpretations resulted in 20 distinct third-order 354 
interpretations. Consequently, each key concept was linked to multiple third-order interpretations; 355 
Organizational Capacity (n=5), Individual Professional Capability (n=4), Communication and 356 
Collaboration (n=3), Attitudes (n=6) and Regulations and Guidelines (n=2). These third order 357 
interpretations, and the CERQual confidence levels associated with them are shown in Table 3 and 358 
supplementary material Table S5. There were eight third-order interpretations in which we have 359 
high confidence. Therefore, we believe it is highly likely that these third-order interpretations are 360 
reasonable representations of the phenomenon of interest.  361 
By linking all 20 third-order interpretations together we developed a ‘line of argument’, which is 362 
outlined below and expressed as a conceptual model in Figure 2. This conceptual model describes 363 
the process of a dysfunctional negative feedback loop where any ‘challenging behavior’ in a person 364 
with dementia promotes either antipsychotic prescribing or a non-pharmacological intervention, or 365 
sometimes both, all with the goal of suppressing the ‘challenging behavior’ and restoring calm. The 366 
‘challenging behavior’ may push decision-making towards an exclusively pharmacological solution, 367 
especially if staff feel overwhelmed. Once the ‘challenging behavior’ is suppressed, the need for an 368 
intervention is reduced. However, the fear that these behaviors may return at any time, or confusion 369 
surrounding roles and responsibilities facilitates maintenance of antipsychotic prescribing, breaking 370 
the feedback loop.  371 
The five key concepts, and eight sub-themes described above, act as the overarching influences on 372 
this decision-making process as a whole.  The conceptual model illustrates that some or all of these 373 
influences may come into play when a ‘challenging behavior’ arises (Fig. 2). These influences interact 374 
with each other, often in an unpredictable and complex manner, and ultimately determine the 375 
response behaviors from staff. 376 
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Our synthesis indicates that different stakeholders struggle to see things from other stakeholders’ 377 
perspective and do not acknowledge the pressure the others are under. However, when all 378 
stakeholders come together to communicate and collaborate as equal and empowered partners the 379 
inappropriate use of antipsychotics can be reduced. 380 
Discussion 381 
This study is the first to our knowledge, to systematically review and synthesize the qualitative 382 
evidence surrounding antipsychotic prescribing in nursing home residents with dementia. 383 
Additionally, we believe that this study is the first to apply CERQual to a meta-ethnography. Our 384 
findings highlight the complexity of this topic and the various influences on decision-making. We 385 
have conceptualized these influences in a ‘line of argument’ that moves beyond the findings of the 386 
individual studies, as a dysfunctional negative feedback loop, which we believe will be useful for 387 
clinicians, researchers and policy-makers.  388 
Comparison with previous research 389 
A systematic review exploring the quantitative relationship between facility characteristics and 390 
antipsychotic usage concluded that in general, as nursing staff levels decrease, antipsychotic usage 391 
increases.41 The authors also reported a positive association between for-profit nursing homes and 392 
antipsychotic usage.41  However these associations are not always clear-cut.42-45 The focus on 393 
qualitative evidence in our review helped us to tease out these more complicated elements. Our 394 
findings reinforce that nursing homes are struggling with understaffing and poor access to important 395 
services. Consequently, staff can become overwhelmed by behaviors in these resource-poor 396 
environments. Nursing home managers, particularly in the for-profit sector, may be tempted to use 397 
antipsychotics as a more economical solution to the problem. However it is important to 398 
acknowledge that the use of antipsychotics as a cost-saving measure appeared in not-for-profit 399 
nursing homes also. 400 
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Knowledge of the risks and benefits of prescribing antipsychotics in dementia has been found to be 401 
quite variable, and often sub-optimal.46-48 Some authors have commented that these deficits in 402 
knowledge may be contributing to a concerning belief that antipsychotics are highly effective for 403 
BPSD.46,47. Furthermore, staff have often been found to be inadequately trained in person-centered 404 
care.46,47,49 Our findings suggest that inadequate skills and knowledge are enabling inappropriate 405 
antipsychotic prescribing. Even in highly capable individuals, we found a tension between doing the 406 
‘right thing’ and doing what’s practical, given resource limitations and their duty of care to other 407 
residents.  408 
Previous research has found that communication breakdown is an impediment to the delivery of 409 
person-centered care,50 and is also a barrier to deprescribing.51 Professional hierarchies in the 410 
nursing home setting have previously been reported as a barrier to evidence-based practice.50,52,53 411 
Furthermore, primary care physicians have expressed frustration at the lack of communication from 412 
hospital consultants with regards  to the management of antipsychotics,54 as well as the pressure to 413 
prescribe from nursing homes.47 Our findings add to this knowledge by identifying a lack of 414 
empowerment at all levels of the healthcare team and among family members as a barrier to 415 
informed antipsychotic prescribing decision-making.  416 
The concept of ‘treatment culture’ in nursing homes has been discussed in the literature in an 417 
attempt to explain why certain nursing homes continue to have high levels of antipsychotic 418 
prescribing independent of residents’ clinical characteristics.55-57 Treatment culture can be defined as 419 
the “beliefs, values, and normative practices associated with medication prescribing and 420 
administration.”56 Nursing homes with a traditional culture (i.e. rigid routines) have been associated 421 
with higher levels of antipsychotic prescribing than those with a resident-centered culture (i.e. 422 
person-centeredness).56 Our research confirms this notion of treatment culture and the impact of 423 
conformity on prescribing decisions. Our findings add to existing evidence by highlighting the 424 
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important role of the manager, who can diffuse a philosophy of person-centered dementia care 425 
throughout the organization.58  426 
Our findings indicate that an underlying fear of behavior recurrence may be one factor driving the 427 
desire for control. Negative connotations of dementia have been described in the literature, 428 
comparing the effect BPSD has on people to becoming “dehumanised.”59  Based on the findings of 429 
our review, we believe that a lack of understanding of the nature and progression of dementia can 430 
lead to the inappropriate maintenance of antipsychotics.  431 
Implications 432 
The conceptualization of decision-making as a dysfunctional negative feedback loop with the 433 
ultimate aim of controlling residents, challenges us in the way we perceive dementia. We need to re-434 
frame the way we view so-called ‘challenging behaviors’. These behaviors may not necessarily be 435 
challenging to the person with dementia – only to us. There have been discussions surrounding the 436 
nuances of terminology in this area, with a term such as ‘responsive behaviors’ being preferable.60 437 
There needs to be an appreciation that these behaviors are generally due to some unmet need,61 438 
and often do not respond to antipsychotics.62,63 Therefore it is imperative that interdisciplinary 439 
training and education is delivered to all involved in the care of residents with dementia, including 440 
family members. 441 
Furthermore, communication structures and interdisciplinary practices need to be optimized in 442 
order to improve the flow of vital information. It is important that peripheral members of this 443 
interdisciplinary team are not excluded from decision-making as they can often hold the key to 444 
successful behavioral management. There is also evidence to support the inclusion of pharmacists in 445 
these teams.8 Shared decision-making, a collaborative process that allows people with dementia, 446 
family members, and their healthcare team to make healthcare decisions together, should be 447 
encouraged.64 Shared decision-making takes into account the best clinical evidence available, as well 448 
as values and preferences of the person with dementia and the family.65 449 
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Our CERQual assessments identify areas that policy-makers can potentially target. For instance, 450 
policy-makers need to carefully re-examine resource allocation issues, as we have high confidence 451 
that nursing homes are utilizing antipsychotics to substitute for inadequate resources and poor 452 
access to specialist services. Given that the use of antipsychotics in this population is not evidence-453 
based, it is concerning that these agents are being used to cut costs. Therefore in light of the 454 
strength of our evidence, we argue that increasing the staff to resident ratio, or increasing access to 455 
services, may possibly result in a reduction in inappropriate antipsychotic prescribing.  456 
We now have a greater understanding of this complex prescribing behavior. However it is still 457 
unclear how it can be sustainably changed.8 Behavior change interventions need to be guided by the 458 
best available evidence and appropriate theory.66 Important contextual issues unique to each 459 
healthcare system need to be explored before pilot studies can be conducted.67 More primary 460 
qualitative research is needed, focusing on aspects that are currently under-researched e.g. 461 
influence of national regulations. It is also crucial that the voice of the person with dementia is 462 
ethically and meaningfully included, either as participants of research,68 or as co-researchers in the 463 
intervention design process.69 Additionally, our conceptual model identified specific influencing 464 
factors, such as confusion surrounding roles and responsibilities, and fear of behavior recurrence. 465 
These identified factors may be suitable for future targeted interventions.  466 
We believe that the interdisciplinary and interdependent nature of this decision-making process is 467 
such that it is unlikely that targeting a single stakeholder group will result in any sustainable change 468 
in prescribing behaviors. Therefore, we argue that a holistic, person-centered approach to behavior 469 
change is required, involving both the prescribers and requesters of antipsychotics.  470 
Strengths and Limitations  471 
The main strength of our study is its robustness. Measures were put in place to ensure the high 472 
quality of the analysis including maintaining reflexivity, utilizing independent multiple analysts and 473 
transparency through careful adherence to the PROSPERO protocol. The study was conducted by an 474 
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experienced multidisciplinary team. Consequently, we believe that our included studies were 475 
analyzed to a high standard and the resultant conceptual model provides the reader with a rich, in-476 
depth and valid new interpretation of a complex phenomenon. 477 
Another strength was the great number and diversity of healthcare professionals and family 478 
members represented in the included studies. The multiple perspectives allows for a more holistic 479 
view of the factors influencing this complex phenomenon. 480 
A limitation of our study, which is true of all systematic reviews of qualitative evidence, is the 481 
difficulty retrieving qualitative research from databases. Unlike randomized controlled trials, 482 
qualitative research has historically been inconsistently indexed in databases, preventing 483 
comprehensive and reproducible searches.70 Therefore it is possible that we may have missed a 484 
potentially relevant study. However, as our team conducted a systematic and thorough search, we 485 
are reasonably confident that we have captured all relevant studies. 486 
Conclusions 487 
Antipsychotic prescribing in nursing home residents with dementia occurs in a complex environment 488 
involving the interplay of various stakeholders (with differing levels of skills and knowledge, who 489 
often have conflicting views on the role of antipsychotics and who may not be equally empowered), 490 
the nursing home organization (with its own treatment culture and level of resources) and external 491 
influences (such as guidelines, regulations and societal influences). In order to improve the quality of 492 
antipsychotic prescribing in this cohort, a paradigm shift is required towards a more holistic 493 
approach to BPSD management. While we have found the issue of antipsychotic prescribing has 494 
been extensively explored using qualitative methods, there remains a need for research focusing on 495 
how best to change the prescribing behaviors identified. 496 
 497 
 498 
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First Author Year 
of 
Public
ation 
Country Study Objectives Methods Data Collection Qualitative 
Data 
Analysis 
Participant characteristics (n) Setting (n) 
Foley 31 2003 US To explore staff perceptions of successful 
management of severe behavioral 
problems in dementia SCUs 
M Structured 
interviews with 
some open ended 
questions 
Content 
analysis 
Nursing staff (19), Activities co-ordinator or Social Worker* 
(4), unit co-ordinators [Nurses or Social Workers]* (9), 
Unknown Staff Role (4). Total participants (36) 
Nursing Home SCUs (36) 
Patterson 
25 
2007 UK To assess the suitability of an American 
model of pharmaceutical care for nursing 
home residents for application in nursing 
homes in the UK 
Q Focus groups and 
semi-structured 
interviews 
Framework Clinical Pharmacists (6), Resident Advocates (6), Prescribing 
Support Pharmacists (14), GPs (8), Nursing Home Managers 
(10). Total participants (44) 
Participants worked in in-
patient, GP, nursing home and 
charity organisations settings 
(unknown numbers) § 
Wood-
Mitchell 26 
2008 UK To examine the process by which 
consultant old age psychiatrists prescribe 
for BPSD and explore the factors that 
influence their decision 
Q Semi-structured 
interviews 
Grounded 
theory 
Consultant Old Age Psychiatrists (8). Total participants (8) 
 
 
Psychiatrists worked in in-
patient and community-care 
settings (unknown numbers) § 
Kolanowsk
i 18 
2010 US To explore nursing, recreational therapy 
and medical staff perceptions of barriers 
to the implementation of non-
pharmacological interventions for BPSD 
Q Focus groups  Content 
and 
thematic 
Registered Nurses, Licensed Practical Nurses, Certified 
Nursing Assistants, Recreational Therapists, Activity 
Personnel and Medical Directors. Total participants (35)† 
Nursing Homes (6) 
Molinari 33 2011 US To explore the justification of 
psychoactive medication prescription for 
new nursing home residents  
M 
 
Chart review with 
follow up focus 
groups 
Content 
and 
thematic 
Licensed Practical Nurses (8), Certified Nursing Assistants 
(20), Registered Nurses (13), Medical Directors (1), Social 
Workers (2). Total participants (44) 
Nursing Homes (7) 
Duxbury 27 2013 UK To explore the views of nurses, and 
relatives regarding the causes of, and 
most effective ways of responding to 
aggressive behaviour from people with 
dementia in residential care settings 
Q Semi-structured 
interviews with 
staff. Focus Groups 
with relatives 
Thematic Dementia Care Unit Manager (4), Registered Nurses (2), 
Care Assistants (2), Relatives (8). Total participants (16) 
 
 
Nursing Homes (4) 
Harding 28 2013 UK To explore carers experiences of the use 
of antipsychotic medications in people 
with dementia  
M Surveys with open 
ended questions 
(online and paper), 
focus groups and 
in-depth interviews  
Inductive 
and 
deductive 
coding. 
Thematic 
Carers and former carers of people with dementia(190). 
Total participants (190) 
 
 
Mixture of own home, nursing 
home and residential home 
(unknown numbers) § 
Janzen 38 2013 Canada To investigate the perceptions of LTC staff 
regarding the current use of NPI for 
reducing agitation in seniors with 
dementia and to identify facilitators and 
barriers that guide NPI implementation 
M Focus groups, semi-
structured 
interviews  and a 
survey with some 
open ended 
questions  
Hermeneut
ic 
phenomen
ology 
Registered Nurses (8), Registered Practical Nurses (13), 
Personal Support Workers (8), Recreation Specialist or 
Coordinators (6), Directors of Care (3), Unit Coordinators 
(2), Recreation Assistant (1), Resident Assessment 
Instrument Coordinator (1), Dietary Specialist (1),  
Art Therapist (1). Total participants (44) 
LTC facilities (5) 
Mavrodari
s 29 
2013 UK To investigate antipsychotic prescribing 
practices and patient review in primary 
care settings 
M Survey with some 
open ended 
questions. 
Thematic GPs (60), care home staff (28). Total participants (88) 
 
GP surgeries (60) and care 
homes (28) § 
Ervin 35 2014 Australi
a 
To explore residential aged care staff 
perceptions of the limitations to five 
commonly used methods of managing 
BPSD; pharmacological therapy and 
Q Survey with open 
ended questions. 
 
Interpretive 
Description 
Division 1 Registered Nurse (33), Division 2 Medication 
Endorsed Registered Nurse (29), Division 2 Registered 
Nurse (34), Personal Care Assistant (14), Students or 
Activities Coordinator (17), Not specified (3). Total 
Residential aged care facilities 
(6) 
Table 1. Characteristics of Included Studies 
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behavioural, emotional, cognitive and 
stimulation therapies 
participants (130) 
Smeets 17 2014 The 
Netherl
ands 
To explore factors that elucidate reasons 
for psychotropic drug prescription for 
neuropsychiatric symptoms in nursing 
home residents with dementia 
Q Semi-structured 
interviews 
Grounded 
theory 
Elderly Care Physician (13), Resident in Elderly Care 
Medicine (1), Medical Doctor (1), Registered Nurses (4), 
Certified Nurse Assistants (9), Nurse Assistant (1). Total 
participants (29) 
Nursing Homes (12) 
Bonner 34 2015 US To describe the rationales that providers 
and family members cite for the use of 
Antipsychotic medications in people with 
dementia living in nursing homes 
M Medical Record 
Abstraction and 
Open ended 
interviews  
Directed 
content 
analysis  
Directors of Nursing (26), Registered Nurses and Licensed 
Practical Nurses (91), Certified Nursing Assistants (244), 
Physicians and Advanced Practitioner Prescribers (27), 
Pharmacists (23), Psychiatrists (14), Family Members (41). 
Total participants (466) 
Nursing Homes (26) 
 
 
Ellis 32 2015 US To explore strategies that have been 
implemented, to assess which strategies 
are evidence-based, and to make 
recommendations to improve upon 
practice to reduce antipsychotic 
medication use 
M Survey with both 
descriptive and 
open-ended 
questions. 
 
Theme-
based 
content 
analysis 
Director of Nursing (109), Nursing Home Administrator 
(95), Social Worker (7), Other Nursing Home Staff (65). 
Total Participants (276) 
 
Nursing Homes (unknown 
number, approximately 227) 
Lawrence 
30 
2015 UK To contribute to an optimised training 
programme for care staff that supports 
the implementation of evidence-based 
psychosocial interventions in long-term 
care 
Q Focus groups  Thematic 
with 
constant 
comparison 
method 
Care Assistants (53), Senior Care Assistants (30), Activity 
Therapists (13), Registered Nurses (6), Deputy Managers 
(5), Managers (2), Other Staff (10). Total participants (119) 
 
Care Homes (16) 
Sawan 36 2016  Australi
a 
To explore how visible artifacts in nursing 
homes influence the prescribing and use 
of psychotropic medicines, and how these 
artifacts were operationalized across 
nursing homes 
Q Semi-structured 
interviews 
Thematic Managers (8), Registered Nurses (8), Nursing Assistants (5), 
GPs (8), Pharmacists (6), Enrolled nurses (2), Specialist 
medical practitioner (1), Nurse Practitioner (1),  
Clinical Nurse Consultant (1). Total participants (40) ‡ 
Nursing Homes (8) 
Sawan 37  2016  Australi
a 
To explore the key dimensions of 
organizational climate and their 
subsequent influence on the use of 
psychotropic medicines 
Q Semi-Structured 
Interviews 
Thematic Managers (8), Registered Nurses (8), Nursing Assistants (5), 
GPs (8), Pharmacists (6), Enrolled nurses (2), Specialist 
medical practitioner (1), Nurse Practitioner (1),  
Clinical Nurse Consultant (1). Total participants (40) ‡ 
Nursing Homes (8) 
Shaw 19 2016 UK To explore and understand treatment 
culture in prescribing of psychoactive 
medications for older people with 
dementia in nursing homes 
Q Semi-structured 
interviews 
Thematic 
and 
framework  
Managers (5), Nurses (7), Care Assistants (13), GPs (2). 
Total participants (27) 
 
 
Nursing homes (6) 
Van Wyk 39 2016 South 
Africa 
To gain an understanding of what care 
home staff perceive to be distressed 
behaviour, their coping strategies and 
how they learned to work with residents 
with behavioral symptoms of dementia. 
Q Semi-structured 
interviews  
Thematic 
and 
framework 
Care Assistants (17). Total participants (17) 
 
 
Care Homes (4) 
Q, Qualitative Methods; M, Mixed Methods; BPSD, Behavioral and Psychological Symptoms of Dementia; NPI, Non-pharmacological interventions; LTC, Long-term care; SCU, Specialist Care Unit; GP, General 678 
Practitioner (also known as Primary Care Physicians). 679 
* Study did not obtain specific degree affiliation, thus unable to distinguish between social workers and nursing staff. † Unknown breakdown of participants. § Research participants may not have been based in a 680 
Nursing Home Setting, but focus of study is on people with dementia in the Nursing Home Setting. ‡ The same study cohort in both studies. 681 
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First Author (Year of 
Publication) 
Clear 
Statement 
Qualitative 
Appropriate 
Research 
Design 
Sampling Data 
Collection 
Reflexivity Ethics Data 
Analysis 
Discussion of 
Findings 
Value Overall Assessment of 
methodological quality 
Foley (2003) 31 √ √ √ ? ? x ? ? √ √ Moderate 
Patterson (2007) 25 √ √ √ √ √ x √ √ √ √ Moderate-to-High 
Wood-Mitchell (2008) 26 √ √ √ ? √ √ ? ? √ √ Moderate-to-High 
Kolanowski (2010) 18 √ √ √ ? ? x √ √ √ √ Moderate-to-High 
Molinari (2011) 33 √ √ √ x ? x ? √ √ √ Moderate 
Duxbury (2013) 27 √ √ √ √ ? x √ √ √ √ Moderate-to-High 
Harding (2013) 28 √ √ √ √ x x ? x x x Low 
Janzen (2013) 38 √ √ √ √ √ √ √ √ √ √ High 
Mavrodaris (2013) 29 √ √ √ √ ? x ? ? √ √ Moderate 
Ervin (2014) 35 √ √ √ √ ? x √ √ √ √ Moderate 
Smeets (2014) 17 √ √ √ ? √ x √ √ √ √ Moderate-to-High 
Bonner (2015) 34 √ √ √ √ √ √ √ x √ √ Moderate 
Ellis (2015) 32 √ √ √ x √ x ? √ √ √ Moderate 
Lawrence (2015) 30 √ √ √ √ √ x √ √ √ √ Moderate-to-High 
Sawan (2016) 36 √ √ √ √ √ √ √ √ √ √ High 
Sawan (2016) 37 √ √ √ √ √ √ √ √ √ √ High 
Shaw (2016) 19 √ √ √ ? √ √ √ √ √ √ High 
Van Wyk (2016) 39 √ √ √ ? ? x ? ? √ √ Moderate 
√, Yes or Methodologically Sound; x, No or Not Methodologically Sound; ?, Can’t tell whether Methodologically sound or not. 682 
Table 2. Quality Appraisal of Included Studies  
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Table 3. CERQual Summary of Qualitative Findings 683 
Review finding/Third-Order Interpretations Relevant papers CERQual 
assessment of 
confidence in the 
evidence 
Explanation of CERQual assessment 
Organizational Capacity 
 1. Chronic under-staffing is a fundamental issue in Nursing Homes, leading to insufficient time and 
ability by Nursing Home staff to perform person-centered care. 
(26, 18, 38, 29, 35, 
17, 32, 30, 37, 19, 
39) 
High confidence Minor concerns regarding 
methodological limitations and 
adequacy 
2. The involvement of specialist services can influence antipsychotic prescribing, but there can 
sometimes be difficulty accessing these services. 
(26, 18, 33, 29, 35, 
17, 34, 32, 36, 37) 
High confidence Minor concerns regarding 
methodological limitations, coherence 
and adequacy. 
3. To circumvent the problems of inadequate resources and/or poor access to specialist services, 
antipsychotics are ‘employed’ as cheap, fast and effective staff members. 
(26, 18, 33, 38, 29, 
35, 17, 32, 30, 19, 
37) 
High  confidence Minor concerns regarding 
methodological limitations and 
adequacy.  
4. As behaviors escalate, a ‘tipping-point’ is reached, after which an urgency to resolve the situation 
arises. This is particularly true when Nursing Home staff feel “overwhelmed” by these behaviors. In 
these situations antipsychotics are perceived by Nursing Home staff to offer a “more guaranteed 
result”. 
(31, 26, 18, 38, 17, 
30, 37) 
Moderate 
confidence 
Minor concerns regarding 
methodological limitations. Moderate 
concerns regarding adequacy 
5. The perceived acuteness of situations forces Nursing Home staff to focus their attention on the 
“aggressive” residents, while the “passive” ones are left behind. Antipsychotics can sometimes be 
viewed as a way of equalizing attention given to both “passive” and “aggressive” residents. 
(18, 38, 35, 17, 30, 
37, 39) 
Low confidence Minor concerns regarding 
methodological limitations. Moderate 
concerns regarding coherence and 
adequacy 
Individual Professional Capability 
6. Both prescribers and Nursing Home staff are often perceived to be poorly equipped to deal with 
BPSD in terms of deficiencies in dementia-specific skills and/or a lack of knowledge on the risk/benefits 
of antipsychotics, and the range and nature of non-pharmacological interventions. These deficiencies 
enable inappropriate antipsychotic prescribing.  
(31, 26, 18, 33, 28, 
38, 29, 35, 17, 34, 
32, 19, 37, 39) 
Moderate 
confidence 
Minor concerns regarding 
methodological limitations and 
relevance. Moderate concerns 
regarding coherence  
7. More training and education to help prescribers and nursing home staff to improve skills and 
knowledge with regards to BPSD management is desired. 
(18, 33, 38, 35, 17, 
34, 32, 30, 37, 39) 
High confidence Minor concerns regarding 
methodological limitations  
8. Even in individuals with sufficient skills and knowledge regarding BPSD management, a tension can (26, 18, 38, 17, 32,  Moderate Minor concerns regarding 
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exist between ‘doing the right thing’ and doing what’s practical, especially if the resources or suitable 
alternatives are not perceived to be there to support adequate implementation. 
30, 19, 36, 37) confidence methodological limitations and 
coherence. Moderate concerns 
regarding adequacy.  
9. Knowing the resident and understanding their behaviors contributes towards successful BPSD 
management. 
(31, 26, 18, 27, 38, 
17, 30, 19, 37, 39) 
High confidence Minor concerns regarding 
methodological limitations and 
adequacy.  
Communication and Collaboration 
10. Effective communication and collaboration (involving sharing information and listening to others) 
between all members of the healthcare team are key enablers to reducing inappropriate prescribing of 
antipsychotics. The involvement of family members can also be important in this process.  
(31, 25, 26, 18, 33, 
27, 28, 38, 29, 17,  
34,  32, 30, 19, 36, 
37) 
High confidence Minor concerns regarding 
methodological limitations, coherence 
and relevance 
11. A lack of empowerment at all levels of the healthcare team and among family members is a barrier 
to informed decision-making regarding antipsychotic prescribing. 
(31, 25, 26, 27, 28, 
29, 17, 32, 30, 19, 
36, 37, 39) 
High confidence Minor concerns regarding 
methodological limitations, coherence 
and relevance.  
12. Fragmentation between different levels of care creates confusion surrounding roles and 
responsibilities, which can lead to inappropriate maintenance of antipsychotics. 
(25, 26, 18, 33, 28, 
29, 32, 36) 
Moderate 
confidence 
Minor concerns regarding adequacy. 
Moderate concerns regarding 
methodological limitations 
Attitudes towards people with dementia and the management of BPSD 
13. Although there is a preference to use non-pharmacological interventions in the first instance due 
to the unpleasant side effects of antipsychotics, it is acknowledged that antipsychotics are a 
“necessary evil” and are often unavoidable. 
(31, 26, 18, 33, 27, 
28, 38, 35, 29, 17, 
32, 30, 19, 36, 37, 
39) 
Moderate 
confidence 
Minor concerns regarding 
methodological limitations and 
relevance. Moderate concerns 
regarding coherence. 
14. Negative attitudes by individuals towards people with dementia can result in inappropriate 
antipsychotic prescribing. Conversely, empathy towards people with dementia can be protective. 
(31, 18, 27, 28, 38, 
35, 17, 30, 19, 36, 
37, 39) 
Moderate 
confidence 
Minor concerns regarding coherence, 
relevance and adequacy. Moderate 
concerns regarding methodological 
limitations 
15. Fear of the recurrence of behaviors motivates maintenance of antipsychotic prescribing. 
(31, 25, 28, 17, 30, 
37, 39) 
Low confidence Minor concerns regarding relevance. 
Moderate concerns regarding 
methodological limitations and 
adequacy 
16. Organizational and societal attitudes towards people with dementia and the management of BPSD, 
exerts pressure on prescribers to make prescribing decisions. 
(25, 26, 18, 27, 28, 
38, 29, 17, 30, 19, 
High confidence Minor concerns regarding 
methodological limitations and 
36 
 
36, 37) coherence.  
17. The attitude of the nursing home manager towards people with dementia and the management of 
BPSD dictates the treatment culture of that nursing home, and this has a strong influence on 
antipsychotic prescribing. 
(27, 38, 32, 30, 19, 
36, 37, 39) 
Moderate 
confidence 
Minor concerns regarding 
methodological limitations. Moderate 
concerns regarding  adequacy 
18. Tensions can arise due to incompatible beliefs towards antipsychotics between prescribers and 
nursing homes; in these cases a battle of wills develops where there is often pressure on prescribers to 
“do something” in order to restore control – doing nothing is not tolerated. However, sometimes 
there is pressure on prescribers to discontinue antipsychotics, to which there can be resistance from 
prescribers. 
(25, 26, 29, 17, 32, 
30, 19, 36, 37) 
Moderate 
confidence 
Minor concerns regarding 
methodological limitations. Moderate 
concerns regarding adequacy 
Regulations and Guidelines 
19. Regulations are perceived to be the driving force for antipsychotic reductions in nursing home 
residents with dementia, but adherence to them can be challenging. 
(18, 33, 34, 32, 36) 
Very low 
confidence 
Moderate concerns regarding 
methodological limitations. 
Substantial concerns regarding 
adequacy 
20. Guidelines exert little influence on antipsychotic prescribing, but may act indirectly to increase 
knowledge regarding the risk/benefits of antipsychotics. 
(26, 29,  17) 
 Very low 
confidence 
Moderate concerns regarding 
methodological limitations. 
Substantial concerns regarding 
adequacy 
BPSD, Behavioral and Psychological Symptoms of Dementia; CERQual, Confidence in the Evidence from Reviews of Qualitative Research. 684 
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